NEW YORK -- Tom Glavine is likely to decline his option with the New York Mets by Friday's deadline, giving the pitcher time to think about his future.

Differing media outlets put the option at between $9 million and $13 million.

Glavine's contract said he must make a decision on the option by the fifth day after the Mets concluded their season.

"Tom and I have been having discussions since Sunday. As he has indicated on prior occasions, he's going to take time with his wife and his family and consider all of his options and then make his decision," Glavine's agent, Gregg Clifton, said Wednesday. "It is doubtful he'll be able to conclude that process prior to Friday."

Glavine went 13-8 with a 4.45 ERA in 34 starts spanning 200 1/3 innings this year, fading in his final three outings. He managed only one out while giving up seven runs to Florida in the first inning an 8-1 loss in the season finale Sunday that knocked New York out of postseason contention.

In other news, All-Star center fielder Carlos Beltran had arthroscopic surgery on both knees Wednesday, and an MRI exam on pitcher John Maine's left hip revealed he doesn't have a sports hernia.

Left-hander Jason Vargas also had a bone spur removed from his pitching elbow. Mets medical director Dr. David Altchek performed the operations on Beltran and Vargas at the Hospital for Special Surgery.

Information from The Associated Press was used in this report.